Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Stability & shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency.

560 FDA drug recalls with this cause, newest first.

These recalls involve products whose stability data no longer supports the expiry date on the label, or that failed a stability test before that date. A medicine that loses potency early does not just stop working as well; it can also change chemically into something FDA never approved. The fix is usually a shorter shelf life for future lots.

Class II · Moderate risk

Anastrozole USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8080-1 D-0475-2018
Class III · Low risk

Azelastine HCl Nasal Solution

Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station

Terminated Stability / shelf life Sun Pharmaceutical Industries, Inc. NDC 47335-779-91 D-0417-2018
Class II · Moderate risk

Neostigmine Methylsulfate

Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

Terminated Stability / shelf life Premier Pharmacy Labs Inc NDC 69623-234-15 D-0129-2018
Class II · Moderate risk

NitroGlycerin

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Terminated Stability / shelf life Advanced Pharma Inc. NDC 15082-863-61 D-0119-2018
Class II · Moderate risk

NitroGlycerin

Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.

Terminated Stability / shelf life Advanced Pharma Inc. NDC 15082-863-67 D-0118-2018
Class II · Moderate risk

VenomX

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-207-01 D-0952-2017
Class II · Moderate risk

StaphWash+Plus+ Skin Protectant

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-101-01 D-0951-2017
Class II · Moderate risk

StingMed Insect bites Skin Protectant. Zinc acetate

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 04307-100-11 D-0950-2017
Class I · High risk

Mibelas 24 Fe

Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.

Terminated Stability / shelf life Lupin Limited (Unit 1) NDC 68180-911-11 D-1093-2017
Class III · Low risk

Benzonatate capsules

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Terminated Stability / shelf life Strides Pharma INC NDC 64380-713-06 D-0858-2017